Equity Profile

DVA

DaVita Inc.

Health CareHealth Care Services$12.3B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

DaVita Inc. is a leading provider of kidney care services, operating dialysis centers and providing related healthcare services....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

N/A

Revenue Growth

Revenue growth is essential for understanding how well DaVita is expanding its services and capturing market share.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

DVA Q2-2026 Earnings Preview

Context

Company Snapshot

DaVita Inc. is a leading provider of kidney care services, operating dialysis centers and providing related healthcare services. As a part of the Health Care sector, DaVita plays a crucial role in managing chronic kidney disease and end-stage renal disease, which affects millions of patients in the U.S.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.03%

Avg Stock Reaction

+0.92%

Last Quarter Recap

In Q1-2026, DaVita reported an EPS of $2.87, exceeding expectations by 19.09%. The stock reacted positively, gaining 1.92% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about DaVita's upcoming earnings, especially after a strong performance last quarter. However, there is uncertainty due to the lack of analyst estimates.

Bull Case

If DaVita can continue its trend of beating EPS estimates, it could signal strong operational performance and growth potential, leading to a positive stock reaction.

Bear Case

On the other hand, if DaVita fails to meet expectations, especially after a strong prior quarter, it could lead to a significant decline in stock value.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

EPS is a critical measure of profitability, and any significant deviation from expectations could impact investor sentiment.

How is DaVita managing costs and revenue growth in the current healthcare environment?

Understanding cost management and revenue growth strategies will provide insights into the company's operational efficiency and future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating DaVita's ability to maintain strong EPS growth despite potential headwinds in the healthcare sector.

Supporting Evidence

DaVita has consistently beaten EPS estimates in the past quarters, suggesting strong operational capabilities.

The options market is pricing in a larger move than historical averages, indicating that traders expect significant volatility.

The company's focus on cost management could lead to better-than-expected profitability.

Key Risk

If EPS comes in below $2.50, it could undermine the positive growth narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is particularly important as it follows a strong Q1-2026, and investors are looking for consistency in earnings.

Bull Confirmed If

An EPS of $3.00 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $2.50 would indicate potential issues in profitability and could lead to a negative market reaction.

Pre-Earnings Positioning

Options Market

Implied Move

±19.68%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings report.

Options are pricing ±19.7% while DVA has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

65.2%

Calls (38K)P/C Ratio: 0.55Puts (4K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DaVita beats expectations, history suggests a potential stock increase of around 1.48%, confirming positive momentum.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may experience a muted reaction.

Miss

Should DaVita miss expectations, history suggests a potential decline of around 0.78%, which could raise concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on profitability.
2Insights into patient volume trends and how they are affecting revenue.
3Comments on competitive pressures in the kidney care market.
4Management's outlook on future growth and any potential challenges.
5Details on any new initiatives or partnerships that could drive growth.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

DaVita Inc. is a leading provider of kidney care services, operating dialysis centers and providing related healthcare services....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

N/A

Revenue Growth

Revenue growth is essential for understanding how well DaVita is expanding its services and capturing market share.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

DVA Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.03%

Avg Stock Reaction

+0.92%

Last Quarter Recap

In Q1-2026, DaVita reported an EPS of $2.87, exceeding expectations by 19.09%. The stock reacted positively, gaining 1.92% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about DaVita's upcoming earnings, especially after a strong performance last quarter. However, there is uncertainty due to the lack of analyst estimates.

Bull Case

If DaVita can continue its trend of beating EPS estimates, it could signal strong operational performance and growth potential, leading to a positive stock reaction.

Bear Case

On the other hand, if DaVita fails to meet expectations, especially after a strong prior quarter, it could lead to a significant decline in stock value.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

EPS is a critical measure of profitability, and any significant deviation from expectations could impact investor sentiment.

How is DaVita managing costs and revenue growth in the current healthcare environment?

Understanding cost management and revenue growth strategies will provide insights into the company's operational efficiency and future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating DaVita's ability to maintain strong EPS growth despite potential headwinds in the healthcare sector.

Supporting Evidence

DaVita has consistently beaten EPS estimates in the past quarters, suggesting strong operational capabilities.

The options market is pricing in a larger move than historical averages, indicating that traders expect significant volatility.

The company's focus on cost management could lead to better-than-expected profitability.

Key Risk

If EPS comes in below $2.50, it could undermine the positive growth narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is particularly important as it follows a strong Q1-2026, and investors are looking for consistency in earnings.

Bull Confirmed If

An EPS of $3.00 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $2.50 would indicate potential issues in profitability and could lead to a negative market reaction.

Pre-Earnings Positioning

Options Market

Implied Move

±19.68%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings report.

Options are pricing ±19.7% while DVA has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

65.2%

Calls (38K)P/C Ratio: 0.55Puts (4K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DaVita beats expectations, history suggests a potential stock increase of around 1.48%, confirming positive momentum.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may experience a muted reaction.

Miss

Should DaVita miss expectations, history suggests a potential decline of around 0.78%, which could raise concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on profitability.
2Insights into patient volume trends and how they are affecting revenue.
3Comments on competitive pressures in the kidney care market.
4Management's outlook on future growth and any potential challenges.
5Details on any new initiatives or partnerships that could drive growth.